C/EBP is an essential component of PDGFRA transcription in MG-63 cells

被引:10
作者
Afink, G [1 ]
Westermark, UK
Lammerts, E
Nistér, M
机构
[1] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden
[2] Karolinska Hosp, Dept Oncol Pathol, Canc Ctr Karolinska, Karolinska Inst, S-17176 Stockholm, Sweden
[3] Univ Nijmegen, Dept Cell Biol, NL-6523 ED Nijmegen, Netherlands
关键词
PDGF; C/EBP; promoter; interleukin; oesteoblast;
D O I
10.1016/j.bbrc.2004.01.056
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-1beta (IL-1beta) is a potent inhibitor of platelet-derived growth factor ot receptor (PDGFRalpha) expression in MG-63 cells. Its effect is mediated at the transcriptional level, but the transcription factors involved in this process are unknown. In the current study, we found that IL-1beta could inhibit the PDGFRalpha gene promoter activity, and this effect was strongly correlated with increased binding of CCAAT/enhancer-binding protein (C/EBP) to the responsive prornoter region. In addition, forced expression of C/EBPbeta could mimic the IL-1beta effect on the promoter activity, but subsequent mutation analysis of the C/EBP binding sites indicated that direct C/EBP binding to the promoter is not required for the IL-1beta response. However, our data clearly demonstrated that the C/EBP binding site at position-162 relative to the transcriptional start site is essential for high basal level PDGFRalpha promoter activity. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 28 条
[1]  
AFINK GB, 1995, ONCOGENE, V10, P1667
[2]   A NUCLEAR FACTOR FOR IL-6 EXPRESSION (NF-IL6) IS A MEMBER OF A C/EBP FAMILY [J].
AKIRA, S ;
ISSHIKI, H ;
SUGITA, T ;
TANABE, O ;
KINOSHITA, S ;
NISHIO, Y ;
NAKAJIMA, T ;
HIRANO, T ;
KISHIMOTO, T .
EMBO JOURNAL, 1990, 9 (06) :1897-1906
[3]  
Ataliotis P, 1997, INT REV CYTOL, V172, P95, DOI 10.1016/S0074-7696(08)62359-1
[4]   ISOFORM-SPECIFIC REGULATION OF PLATELET-DERIVED GROWTH-FACTOR ACTIVITY AND BINDING IN OSTEOBLAST-ENRICHED CULTURES FROM FETAL-RAT BONE [J].
CENTRELLA, M ;
MCCARTHY, TL ;
KUSMIK, WF ;
CANALIS, E .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (04) :1076-1084
[5]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[6]   CDNA CLONING AND EXPRESSION OF THE HUMAN A-TYPE PLATELET-DERIVED GROWTH-FACTOR (PDGF) RECEPTOR ESTABLISHES STRUCTURAL SIMILARITY TO THE B-TYPE PDGF RECEPTOR [J].
CLAESSONWELSH, L ;
ERIKSSON, A ;
WESTERMARK, B ;
HELDIN, CH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) :4917-4921
[7]   HIGH-AFFINITY BINDING OF PDGF-AA AND PDGF-BB TO NORMAL HUMAN OSTEOBLASTIC CELLS AND MODULATION BY INTERLEUKIN-1 [J].
GILARDETTI, RS ;
CHAIBI, MS ;
STROUMZA, J ;
WILLIAMS, SR ;
ANTONIADES, HN ;
CARNES, DC ;
GRAVES, DT .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (06) :C980-C985
[8]  
GRONWALD RGK, 1989, J BIOL CHEM, V264, P8120
[9]   New members of the platelet-derived growth factor family of mitogens [J].
Heldin, CH ;
Eriksson, U ;
Östman, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 398 (02) :284-290
[10]   Mechanism of action and in vivo role of platelet-derived growth factor [J].
Heldin, CH ;
Westermark, B .
PHYSIOLOGICAL REVIEWS, 1999, 79 (04) :1283-1316